Muenke Syndrome Overview
Learn About Muenke Syndrome
Muenke syndrome is a condition characterized by the premature closure of certain bones of the skull (craniosynostosis) during development, which affects the shape of the head and face.
A particular mutation in the FGFR3 gene causes Muenke syndrome. The FGFR3 gene provides instructions for making a protein that is involved in the development and maintenance of bone and brain tissue. The mutation associated with Muenke syndrome causes the FGFR3 protein to be overly active, which interferes with normal bone growth and allows the bones of the skull to fuse before they should.
Muenke syndrome occurs in about 1 in 30,000 newborns. This condition accounts for an estimated 4 percent of all cases of craniosynostosis.
This condition is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder.
Erasmus MC
Eppo Wolvius practices in Rotterdam, Netherlands. Wolvius is rated as a Distinguished expert by MediFind in the treatment of Muenke Syndrome. Their top areas of expertise are Micrognathia, Muenke Syndrome, Crouzon Syndrome, Osteotomy, and Bone Graft.
Erasmus MC
Irene Mathijssen practices in Rotterdam, Netherlands. Ms. Mathijssen is rated as a Distinguished expert by MediFind in the treatment of Muenke Syndrome. Her top areas of expertise are Craniosynostosis, Metopic Ridge, Plagiocephaly, Osteotomy, and Adenoidectomy.
Irene Mathijssen practices in Rotterdam, Netherlands. Mathijssen is rated as a Distinguished expert by MediFind in the treatment of Muenke Syndrome. Their top areas of expertise are Muenke Syndrome, Metopic Ridge, Plagiocephaly, Saethre-Chotzen Syndrome, and Osteotomy.
Published Date: March 01, 2019
Published By: National Institutes of Health